(3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide

C39H51F3N8O13 — CID 155301913

IUPAC(3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide
SMILESNC[C@H]1O[C@@H](O[C@@H](C(NCCCNC(=O)NCc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)C(N)=O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)C(O)C2O)[C@H](O)[C@@H]1O
InChIInChI=1S/C39H51F3N8O13/c40-39(41,42)63-24-8-6-22(7-9-24)59-23-10-15-49(16-11-23)21-4-2-20(3-5-21)19-47-37(57)46-14-1-13-45-27(34(44)56)32(62-36-31(55)28(52)25(18-43)60-36)33-29(53)30(54)35(61-33)50-17-12-26(51)48-38(50)58/h2-9,12,17,23,25,27-33,35-36,45,52-55H,1,10-11,13-16,18-19,43H2,(H2,44,56)(H2,46,47,57)(H,48,51,58)/t25-,27?,28-,29?,30?,31-,32+,33+,35-,36+/m1/s1
InChIKeyFVQMAXUMYULTNX-VOVMOCOTSA-N
MW896.87 g/mol
LogP-1.77
Rot. Bonds18

About (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide

(3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide (PubChem CID 155301913) has the molecular formula C39H51F3N8O13 and a molecular weight of 896.87 g/mol. Its IUPAC name is (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide.

Molecular Properties

Compound Name(3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide
PubChem CID155301913
Molecular FormulaC39H51F3N8O13
Molecular Weight896.87 g/mol
Exact Mass896.35
IUPAC Name(3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide
SMILESNC[C@H]1O[C@@H](O[C@@H](C(NCCCNC(=O)NCc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)C(N)=O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)C(O)C2O)[C@H](O)[C@@H]1O
InChIInChI=1S/C39H51F3N8O13/c40-39(41,42)63-24-8-6-22(7-9-24)59-23-10-15-49(16-11-23)21-4-2-20(3-5-21)19-47-37(57)46-14-1-13-45-27(34(44)56)32(62-36-31(55)28(52)25(18-43)60-36)33-29(53)30(54)35(61-33)50-17-12-26(51)48-38(50)58/h2-9,12,17,23,25,27-33,35-36,45,52-55H,1,10-11,13-16,18-19,43H2,(H2,44,56)(H2,46,47,57)(H,48,51,58)/t25-,27?,28-,29?,30?,31-,32+,33+,35-,36+/m1/s1
InChIKeyFVQMAXUMYULTNX-VOVMOCOTSA-N
XLogP-1.77
TPSA307.44 Ų
H-Bond Donors10
H-Bond Acceptors17
Rotatable Bonds18
Heavy Atoms63
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500896.87
LogP ≤ 5-1.77
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide?
The IUPAC name of (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide (CID 155301913) is (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide.
What is the SMILES notation for (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide?
The canonical SMILES for (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide is NC[C@H]1O[C@@H](O[C@@H](C(NCCCNC(=O)NCc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)C(N)=O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)C(O)C2O)[C@H](O)[C@@H]1O.
What is the InChIKey of (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide?
The InChIKey is FVQMAXUMYULTNX-VOVMOCOTSA-N. The full InChI is InChI=1S/C39H51F3N8O13/c40-39(41,42)63-24-8-6-22(7-9-24)59-23-10-15-49(16-11-23)21-4-2-20(3-5-21)19-47-37(57)46-14-1-13-45-27(34(44)56)32(62-36-31(55)28(52)25(18-43)60-36)33-29(53)30(54)35(61-33)50-17-12-26(51)48-38(50)58/h2-9,12,17,23,25,27-33,35-36,45,52-55H,1,10-11,13-16,18-19,43H2,(H2,44,56)(H2,46,47,57)(H,48,51,58)/t25-,27?,28-,29?,30?,31-,32+,33+,35-,36+/m1/s1.
What are the key properties of (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide?
(3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide has a molecular weight of 896.87 g/mol, XLogP of -1.77, 18 rotatable bonds, 10 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-[3-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenyl]methylcarbamoylamino]propylamino]propanamide is sourced from PubChem (CID 155301913), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).